DNA

Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update

All dollar amounts reflected in Canadian dollars unless otherwise statedVANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics…

1 month ago

Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset

Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset Research presented at…

1 month ago

Rakovina Therapeutics Announces Private Placement Offering

The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the OfferingVANCOUVER, British Columbia, Nov.…

1 month ago

ChemAI: AI-Driven Digital Chemistry Pioneer announces Strategic Rebrand and Key Board Appointments

LEEDS, England, Nov. 27, 2024 /PRNewswire/ -- Deepmatter, a leading innovator in digital chemistry, today unveils its rebrand to ChemAI, as part…

1 month ago

Prenetics Announces Third Quarter 2024 Financial Results

Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand…

1 month ago

My Compounding of Brisbane Now Offers Compounding Services Across Australia

BRISBANE, AUSTRALIA / ACCESSWIRE / November 26, 2024 / The healthcare landscape in Australia has taken a significant stride forward…

1 month ago

Leading Allergan Trainer Dr. Rubinstein Selected for FDA-Approved BOTOX(R) Cosmetic Treatment of Platysma Bands in Montvale, NJ

Renowned Facial Plastic Surgeon Dr. Rubinstein has been selected to train professionals on FDA-approved BOTOX® Cosmetic for neck rejuvenation in…

1 month ago

IMUNON Announces Results from its End-of-Phase 2 Meeting with the FDA for its Lead IMNN-001 Clinical Program in Advanced Ovarian Cancer

FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment schedule,…

1 month ago

Recludix Pharma to Participate in Two Investor Conferences in December

SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in discovery of inhibitors of challenging targets for…

1 month ago